Systemic lupus erythematosus (SLE) is a complex and potentially life-threatening autoimmune disease. Part of the complexity stems from how it can differ from person to person—giving rise to marked ...

Please provide your email address to receive an email when new articles are posted on . Antimalarials, azathioprine, colchicine, cyclosporine, sulfasalazine and tacrolimus are deemed compatible with ...

BARCELONA, Spain--(BUSINESS WIRE)--Hospital for Special Surgery (HSS) presented a research study at the European Alliance of Associations for Rheumatology (EULAR) Annual Meeting showing that an ...

Biogen Inc. (NASDAQ:BIIB) is one of the 11 most profitable NASDAQ stocks to buy now. On June 12, UCB and Biogen presented additional detailed results from the Phase 3 PHOENYCS GO study, evaluating ...

"Psoriatic arthritis and axial spondyloarthritis are serious, chronic inflammatory diseases that can have a great impact in the daily lives of patients and their families. The data presented at EULAR ...

In 2023, EULAR welcomed Professor Daniel Aletaha to the role, but it is now time for him to hand the baton on to the next in line. We are delighted to have Xenofon Baraliakos as the new EULAR ...

Enlivex Therapeutics Ltd., a clinical-stage immunotherapy company based in Ness-Ziona, Israel, announced it will present data on Allocetra™, its proprietary macrophage reprogramming cell therapy for ...

Fate Therapeutics' off-the-shelf cell therapy product platform, including FT819, is gaining significant exposure by being selected for an oral presentation at the prominent EULAR 2025 congress. The ...

Additional information, including the accepted abstracts, can be accessed on the EULAR 2025 Congress website. Presentation materials will be made available in the Science section under Scientific ...

Many rheumatologic conditions such as rheumatoid arthritis and lupus often strike women during their reproductive years, with drugs being the primary therapies. Experts assembled by EULAR determined ...